TJM Labs Closes $10M Series A Led by Arthur Ventures

We’re excited to share that TJM Labs has closed a $10M Series A funding round led by Arthur Ventures.

Since launching, we’ve been focused on one mission: helping pharmacies operate more efficiently through AI-powered automation. Our platform replaces repetitive, time-consuming tasks that pharmacy technicians handle every day, giving pharmacy teams time back to focus on what matters most: patient care.

Today, TJM Labs is processing millions of prescriptions across the US and Canada. We work with pharmacies running everything from modern cloud-based systems to legacy platforms. Our AI bots adapt to each pharmacy management system, handle the unexpected, and continuously learn as they go.

This funding allows us to accelerate product development, expand our team, and serve more pharmacies across the globe. We’re grateful to partner with Arthur Ventures, who share our vision for transforming pharmacy operations through intelligent automation.

To the pharmacy owners and teams who have trusted us with their workflows: thank you. This is just the beginning.

If you’re interested in learning how TJM Labs can help your pharmacy operate more efficiently, book a demo with our team.

‍